Science & Society News
Learn what is happening inside the Duke Initiative for Science & Society. Stay up-to-date on our research, events, and student activities.
Wed, Feb 21
It’s HIPAA, not HIPPA
People often have the misconception that HIPAA is a health privacy law that protects all health data and gives them a right not to disclose their sensitive information. The unfortunate truth is that the “Health Insurance Portability and Accountability Act” is far from the privacy law most people believe it to be. HIPAA only applies to a select group of organizations like medical providers and insurers called “covered entities” and associated entities called “business associates.” In the past few years, there has been an explosion of digital health websites and mobile apps that collect, store, use, and sell health data. However, the majority of services don’t connect users with a medical provider or require health insurance and therefore, are not covered by the data protections and regulations imposed by HIPAA.
To better understand the evolving environment of non-HIPAA-covered health data, I attended Duke’s Data Privacy Day—a two-panel conference at the Duke Law School on February 2nd. In the first panel, privacy expert Marc Groman and medical provider Dr. David Reitman discussed the data privacy concerns of mental health apps. David highlighted how health providers see mental health apps as an outside-the-box solution for the current shortage of mental health professionals, while Marc underscored how mental health apps turn patients into products by selling sensitive health information collected during services. By hearing from both a privacy and medical perspective, the discussion shed light on the tension between the duty of care and the right to privacy while providing a relevant example of a category of apps that collect health data, not subject to HIPAA regulation.
The second panel, composed of privacy experts with distinctive backgrounds, discussed potential solutions to the growing quantity of non-HIPAA-covered health data. The panel generated interdisciplinary conversations about solutions to protecting health data while maximizing its benefit to society. Each panelist brought a unique perspective to the table, attuned to the concerns, limitations, and arguments in their respective fields. Dr. Rachele Hendricks-Sturrup, who is a Duke Health Policy Researcher in Real-World Evidence, was particularly attuned to how non-health data, like location data or credit card data, can infer information about your health. Maneesha Mithal, lawyer and former leader of the FTC’s Division of Privacy and Identity Protection, expanded on the FTC’s evolving role in protecting health data.
Health data privacy is a complex problem that requires a diverse set of perspectives and expertise to solve. Duke’s Data Privacy Day is just one example of the co-curricular events sponsored by Science & Society that focus on creating an environment where interdisciplinary conversations are welcomed and thrive. As an MA in Bioethics and Science Policy student, I frequently engage in classroom dialogue with fellow students and professors. However, the hallmark of my education thus far is events like Data Privacy Day where I can interact with and learn from experts around the world, gaining insight into the most pertinent conversations in ethics and policy.
Join the Conversation. Learn More:
Liz Sparacino, Duke MA in Tech Ethics & Policy
Liz Sparacino enrolled in the Duke Master of Arts in Bioethics & Science Policy to better understand how to articulate and advocate for the bioethical issues that arise at intersection of science, technology, and society. Throughout her career, she hopes to address these concerns before new genetic technology is implemented and to continue to advocate for people with disabilities.
DISCLAIMER: These reflections represent the views of the student and not necessarily the views of the Duke Initiative for Science & Society or the Bioethics & Science Policy Masters Program. Our program represents myriad views and ideologies and we welcome open discussion on potentially controversial subject matter as it relates to society.
Mon, Feb 12
White House Investing $5 billion in Chips: Here’s What To know
Mon, Feb 05
Elon Musk Says Neuralink Has Implanted Its First Brain Chip In Human
Elon Musk, the billionaire founder of the neurotechnology company Neuralink, has said the first human received an implant from the brain-chip startup and is recovering well.
Tue, Jan 02
The Genes That Made Us Truly Human May Also Make Us Ill
Our ancestors’ brains quadrupled in size, allowing greater behavioral flexibility, while modifications to the tongue and vocal cords contributed to the development of human speech and language. Ancient humans acquired skeletal, muscle and joint modifications which allowed them to walk upright, move across large distances, and grasp and throw projectile weapons.
However, although these rapid genetic changes may once have helped us adapt to our environment, scientists now believe they may have increased the risk of developing diseases such as Alzheimer’s, schizophrenia, bipolar disorder, diabetes, and osteoarthritis.
Wed, Dec 27
Microsoft-OpenAI: Should Antitrust Regulators Be Worried?
Just after a victory in acquiring game studio Activision Blizzard, Microsoft (MSFT) could have jumped to the front of the line for regulators seeking to stamp out potential antitrust cases. Sam Altman has been reinstated as OpenAI CEO after a brief courting by Microsoft — which owns a 49% stake in the artificial intelligence firm — and now the two companies are chummier than ever.
Duke University Professor and Venture Capitalist Sultan Meghji and Axios Tech and Policy Reporter Ashley Gold comment on how the OpenAI melodrama could change lawmakers’ antitrust frameworks.
“We’re going to be in a situation, I’m positive, where the output of the last five days of chaos at OpenAI will fundamentally shift the regulatory lens back to the Big Tech companies that are writing these checks,” Meghji, former CIO of the Federal Deposit Insurance Corp (FDIC), tells Yahoo Finance. “Previous to this, Microsoft did not have a board seat, they were not even board observers at OpenAI. It’s very clear that they will.”